These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9038732)

  • 101. Detection of keratin subtypes in routinely processed cervical tissue: implications for tumour classification and the study of cervix cancer aetiology.
    Smedts F; Ramaekers F; Link M; Lauerova L; Troyanovsky S; Schijf C; Vooijs GP
    Virchows Arch; 1994; 425(2):145-55. PubMed ID: 7524976
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Evaluation of PTEN expression in cervical adenocarcinoma by tissue microarray.
    El-Mansi MT; Williams AR
    Int J Gynecol Cancer; 2006; 16(3):1254-60. PubMed ID: 16803514
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The prognostic value of p53 expression for patients with cervical cancer: a meta analysis.
    Zhou R; Wei C; Liu J; Luo Y; Tang W
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():210-213. PubMed ID: 26595307
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Progression of cervical carcinomas is associated with down-regulation of CD9 but strong local re-expression at sites of transendothelial invasion.
    Sauer G; Windisch J; Kurzeder C; Heilmann V; Kreienberg R; Deissler H
    Clin Cancer Res; 2003 Dec; 9(17):6426-31. PubMed ID: 14695144
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Gene Expression Analysis for Uterine Cervix and Corpus Cancer Characterization.
    Almorox L; Antequera L; Rojas I; Herrera LJ; Ortuño FM
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540371
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Prognostic Utility of CD47 in Cancer of the Uterine Cervix and the Sensitivity of Immunohistochemical Scores.
    Yordanov A; Shivarov V; Kostov S; Ivanova Y; Dimitrova P; Popovska S; Tsoneva E; Vasileva-Slaveva M
    Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611344
    [TBL] [Abstract][Full Text] [Related]  

  • 107. The Role of p53 Gene in Cervical Carcinogenesis.
    Garima ; Pandey S; Pandey LK; Saxena AK; Patel N
    J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):383-8. PubMed ID: 27651634
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Immunophenotype and human papillomavirus status of serous adenocarcinoma of the uterine cervix.
    Togami S; Sasajima Y; Kasamatsu T; Oda-Otomo R; Okada S; Ishikawa M; Ikeda S; Kato T; Tsuda H
    Pathol Oncol Res; 2015 Apr; 21(2):487-94. PubMed ID: 25370301
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Expression of E6, p53 and p21 proteins and physical state of HPV16 in cervical cytologies with and without low grade lesions.
    Tagle DK; Sotelo DH; Illades-Aguiar B; Leyva-Vazquez MA; Alfaro EF; Coronel YC; Hernández Odel M; Romero Ldel C
    Int J Clin Exp Med; 2014; 7(1):186-93. PubMed ID: 24482706
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Expression of cyclins, p53, and Ki-67 in cervical squamous cell carcinomas: overexpression of cyclin A is a poor prognostic factor in stage Ib and II disease.
    Shiohara S; Shiozawa T; Miyamoto T; Feng YZ; Kashima H; Kurai M; Suzuki A; Konishi I
    Virchows Arch; 2005 Jun; 446(6):626-33. PubMed ID: 15891905
    [TBL] [Abstract][Full Text] [Related]  

  • 111. p53 immunohistochemical expression of Egyptian cervical carcinoma.
    Abd El All H; Rye A; Duvillard P
    Pathol Oncol Res; 1999; 5(4):280-4. PubMed ID: 10607922
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Prognostic significance of the bcl-2 apoptotic family of proteins in primary and recurrent cervical cancer.
    Crawford RA; Caldwell C; Iles RK; Lowe D; Shepherd JH; Chard T
    Br J Cancer; 1998 Jul; 78(2):210-4. PubMed ID: 9683295
    [TBL] [Abstract][Full Text] [Related]  

  • 113. P53 immunohistochemical expression: messages in cervical carcinogenesis.
    Cheah PL; Looi LM
    Pathology; 2002 Aug; 34(4):326-31. PubMed ID: 12190289
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Tissue expression of human epididymal secretory protein 4 may be useful in the differential diagnosis of uterine cervical tumors.
    Diniz G; Karadeniz T; Sayhan S; Akata T; Aydiner F; Ayaz D; Solakoglu Kahraman D; Akman T
    Ginekol Pol; 2017; 88(2):51-55. PubMed ID: 28326512
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
    Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
    Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The pathology of cervical tumours.
    Tiltman AJ
    Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):485-500. PubMed ID: 16150389
    [TBL] [Abstract][Full Text] [Related]  

  • 117. p53 expression in carcinoma of the cervix.
    Hunt CR; Hale RJ; Buckley CH; Hunt J
    J Clin Pathol; 1996 Dec; 49(12):971-4. PubMed ID: 9038732
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Cervical squamous dysplasias and carcinomas with immunodetectable p53 frequently contain HPV.
    Mittal KR; Lin O; Chan W; Goswami S; Demopoulos RI
    Gynecol Oncol; 1995 Sep; 58(3):289-94. PubMed ID: 7672694
    [TBL] [Abstract][Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.